首页> 外文期刊>Journal of thrombosis and haemostasis: JTH >Standardization of von Willebrand factor propeptide: Value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316)
【24h】

Standardization of von Willebrand factor propeptide: Value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316)

机译:von Willebrand因子前肽的标准化:分配给WHO 6th IS Factor VIII / von Willebrand因子,血浆的价值(07/316)

获取原文
获取原文并翻译 | 示例
       

摘要

The ratio of von Willebrand factor propeptide (VWFpp) to VWF antigen (VWF:Ag) in plasma has been used to identify conditions associated with decreased half-life of VWF (e.g. type 1 von Willebrand disease with increased clearance, and acquired von Willebrand syndrome) [1-3]. Although there is an established international unit (IU) for VWF:Ag, currently assigned to the WHO 6th IS Factor VIII/VWF Plasma (07/316), there is no IU for VWFpp. Laboratories therefore rely on local or 'unofficial' reference preparations for VWFpp estimation, primarily comprising plasma pools with arbitrary 'plasma-based' units. This situation has the potential for considerable inter-laboratory variability as well as problems of continuity when local references are replaced. The present study was undertaken to assess the inter-laboratory variability of VWFpp (and VWF:Ag) estimates and to assign a value for VWFpp to the WHO 6th IS Factor VIII/VWF Plasma (WHO IS Plasma). Assignment of a value to the WHO IS Plasma will provide long-term continuity for the VWFpp unit and should lead to improved agreement between laboratories by providing a traceable route for the calibration of all local reference preparations.
机译:血浆中血浆血管性血友病因子前肽(VWFpp)与血管性血友病抗原(VWF:Ag)的比率已用于鉴定与血管性血友病半衰期缩短相关的疾病(例如,清除率增加的1型血管性血友病和获得性血管性血友病综合征) )[1-3]。尽管目前已为WHO 6th IS Factor VIII / VWF血浆(07/316)分配了VWF:Ag的国际单位(IU),但VWFpp没有IU。因此,实验室依靠本地或“非官方”参考制剂进行VWFpp估算,主要包括具有任意“基于血浆”单位的血浆库。当替换本地参考文献时,这种情况可能会导致实验室间的巨大差异以及连续性问题。进行本研究以评估VWFpp(和VWF:Ag)估计值的实验室间变异性,并将VWFpp的值分配给WHO 6th IS Factor VIII / VWF血浆(WHO IS血浆)。为WHO IS Plasma分配值将为VWFpp装置提供长期的连续性,并应通过为所有本地参考制剂的校准提供可追溯的途径来改善实验室之间的一致性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号